Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LOX | P28300 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL125010 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL6712839 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL5702427 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL64468 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL1022858 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| Lithium Ion SCHEMBL1021741 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL3151431 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL8090124 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL10724821 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB | |
| SCHEMBL3146039 | 0.94 | EPHX1 (0.37) | EPHX1HPGDEPHX2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119143639-A | Synthesis method of methane bis (benzenesulfonate) | 苏州华道生物药业股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| WO-2004039813-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CHLORO METHYL CEPHEM DERIVATIVES | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2004-05-13 | — | — | WO | claimed |
| US-20040002600-A1 | Process for the conversion of penam ring system to cepham ring system | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2004-01-01 | — | — | US | claimed |
| WO-2004000848-A1 | PROCESS FOR THE CONVERSION OF PENAM RING SYSTEM TO CEPHAM RING SYSTEM | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2003-12-31 | — | — | WO | claimed |
| CN-119143639-A | Synthesis method of methane bis (benzenesulfonate) | 苏州华道生物药业股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| WO-2004039813-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CHLORO METHYL CEPHEM DERIVATIVES | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2004-05-13 | — | — | WO | disclosed |
| US-20040002600-A1 | Process for the conversion of penam ring system to cepham ring system | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2004-01-01 | — | — | US | disclosed |
| WO-2004000848-A1 | PROCESS FOR THE CONVERSION OF PENAM RING SYSTEM TO CEPHAM RING SYSTEM | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040002600-A1 | Process for the conversion of penam ring system to cepham ring system | CBR1, CBR3, CD79B | EPHX1 1261/4885HPGD 1607/4885EPHX2 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.